Large Cap

Auto Watchdog Intensifies Probe Into Tesla's Autopilot Recall As Safety Concerns Mount
Strong Quarterly Earnings Fuel Market Optimism Despite Inflation Concerns, Slowing Economic Growth: This Week In The Market
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
Strong Quarterly Earnings Fuel Market Optimism Despite Inflation Concerns, Slowing Economic Growth: This Week In The Market
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
Arthritis Patients - Cigna's Evernorth To Offer Humira Biosimilar At No Out-of-Pocket Cost
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia

Large Cap Recent News

Production Up, Profit Down: Imperial Oil Navigates Seasonal Trends In Q1
Imperial Oil reported higher first-quarter EPS and Upstream production, but lower net income. Dividend declared and carbon capture project initiated.
Why Is HCA Healthcare Stock Trading Lower On Friday?
HCA Healthcare's first-quarter results, surpassing revenue and EPS expectations. CEO Sam Hazen emphasizes sustained momentum and volume growth.
Why Petroleum Refineries Major Phillips 66 Shares Are Falling Today
Phillips 66 reported Q1 FY24 results with revenue of $36.436B and adjusted EPS of $1.90 missing consensus of $2.17.
Ex-Humira Growth Platform Drives AbbVie's Q1 Performance, Drugmaker Lifts Annual Profit Outlook
AbbVie impresses with Q1 results: EPS beats at $2.31 (-6.1% Y/Y), net revenue exceeds at $12.31 billion (+0.7%). Notable: Immunology sales, Humira vs. biosimilars, oncology gains.
Exxon Mobil's Stock Slides Following Q1 Earnings - Here's Why
Exxon Mobil reported Q1 results, beating revenue expectations. Net profit down due to refining margins and gas prices. Declares dividend.
Anglo American Rejects BHP's 'Highly Unattractive' Bid, Sets Proposal Deadline For May 22
"The BHP proposal is opportunistic and fails to value Anglo American's prospects," the board chair said.
Alphabet CFO Underscores Google's $12B Capex Surge: 'Reflects Our Confidence In The Opportunities Offered By AI'
Alphabet announced a significant increase in its capital expenditure, reflecting the company's strong financial performance and its commitment to AI.
Labcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Deal
Labcorp beats Q1 sales estimates, driven by organic growth and acquisitions. Revised 2024 guidance projects higher EPS and sales growth. The acquisition of Invitae is expected to bolster Labcorp's specialty testing capabilities.
Gold Glitters On Stagflation Tailwinds: Newmont Soars 13% In Biggest Post-Covid Gain, Leads Mining Sector Surge
Newmont outperforms expectations, sparking a rally in the gold mining industry despite weak investor sentiment. Strong Q1 performance and dividend declared.
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
AbbVie's Upadacitinib outperforms dupilumab in Phase 3b/4 study for atopic dermatitis treatment, achieving superior efficacy and rapid skin clearance than Dupixent.
What's Going On With Pfizer Stock On Thursday?
GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying high-stakes legal battles in the U.S.
Why Personal Products Major Unilever Shares Are Rising Today
Unilever's Q1 FY24 earnings showed revenue growth and strong performance from its Power Brands, Beauty & Wellbeing, Personal Care, and Home Care segments.
Stocks Drop, Tech Tumbles With Meta's Weak Outlook, Q1 Stagflation Fears; Gold Miners Advance: What's Driving Markets Thursday?
Wall Street suffers a double blow in Thursday’s session, as softer-than-expected revenue forecasts from Meta Platforms Inc. (NASDAQ:META) are being compounded by weaker-than-expected economic growth and higher inflationary pressures last quarter, raising fears of a stagflation phase

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Stock Brokers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers